Sitagliptin

• Description :

  Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  407.32

• Molecular Formula :

  C16H15F6N5O

• Notes :

  Research use only, not for human use.

• Receptor :

  DPP-4

• CAS Number :

  486460-32-6